Protocol: Add-on or switch to vibegron in patients with overactive bladder insufficiently responding to initial 4-week antimuscarinics: a randomised, parallel-group, multicentre trial (ADVISR) protocol
(24 March, 2025)
Takanobu Yamamoto, Soichiro Yoshida, Yuya Maezawa, Takashi Tamiya, Masahiro Toide, Hiroshi Fukushima, Sho Uehara, Saori Araki, Masaya Ito, Shuichiro Kobayashi, Atsushi Yoshinaga, Naoko Kawamura, Ryoji Takazawa, Yasuyuki Sakai, Yukihiro Ootsuka, Tetsuro Tsukamoto, Katsushi Nagahama, Hajime Tanaka, Ryo Kitabayashi, Ryoichi Hanazawa, Megumi Ishiguro, Hiroyuki Sato, Ryuji Koike, Yasuhisa Fujii